118 related articles for article (PubMed ID: 36045565)
1. Serum lipopolysaccharide-binding protein levels and cardiovascular events in hemodialysis patients: A prospective cohort study.
Lin TY; Chang YK; Wu MY; Wu TK; Chen CH; Lim PS
Nephrology (Carlton); 2022 Nov; 27(11):877-885. PubMed ID: 36045565
[TBL] [Abstract][Full Text] [Related]
2. Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.
Lim PS; Chang YK; Wu TK
Blood Purif; 2019; 47(1-3):28-36. PubMed ID: 30219816
[TBL] [Abstract][Full Text] [Related]
3. Serum Lipopolysaccharide-Binding Protein Levels and the Incidence of Cardiovascular Disease in a General Japanese Population: The Hisayama Study.
Asada M; Oishi E; Sakata S; Hata J; Yoshida D; Honda T; Furuta Y; Shibata M; Suzuki K; Watanabe H; Murayama N; Kitazono T; Yamaura K; Ninomiya T
J Am Heart Assoc; 2019 Nov; 8(21):e013628. PubMed ID: 31657258
[TBL] [Abstract][Full Text] [Related]
4. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
5. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.
Yong K; Dogra G; Boudville N; Lim W
Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485
[TBL] [Abstract][Full Text] [Related]
6. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.
Hassan MO; Duarte R; Dix-Peek T; Vachiat A; Naidoo S; Dickens C; Grinter S; Manga P; Naicker S
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):131-135. PubMed ID: 27509588
[TBL] [Abstract][Full Text] [Related]
7. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
8. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
Bostom AG; Shemin D; Verhoef P; Nadeau MR; Jacques PF; Selhub J; Dworkin L; Rosenberg IH
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2554-8. PubMed ID: 9409227
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study.
Nopp S; Königsbrügge O; Schmaldienst S; Klauser-Braun R; Lorenz M; Pabinger I; Säemann M; Ay C
Nephrol Dial Transplant; 2023 Jul; 38(8):1836-1847. PubMed ID: 36472548
[TBL] [Abstract][Full Text] [Related]
10. Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients.
Osawa H; Nakamura N; Tsutaya C; Saitoh H; Shimada M; Murakami R; Fujita T; Narita-Kinjo I; Nagawa D; Nakata M; Yokota T; Ohyama C; Tomita H
In Vivo; 2024; 38(3):1351-1358. PubMed ID: 38688654
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.
Sakura T; Morioka T; Shioi A; Kakutani Y; Miki Y; Yamazaki Y; Motoyama K; Mori K; Fukumoto S; Shoji T; Emoto M; Inaba M
Cardiovasc Diabetol; 2017 May; 16(1):62. PubMed ID: 28486964
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
Nilsson E; Cao Y; Lindholm B; Ohyama A; Carrero JJ; Qureshi AR; Stenvinkel P
Nephrol Dial Transplant; 2018 Jun; 33(6):971-977. PubMed ID: 28992321
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells: a novel predictor of morbidity among hemodialysis patients.
Balakrishnan VS; Schmid CH; Jaber BL; Natov SN; King AJ; Pereira BJG
J Am Soc Nephrol; 2000 Nov; 11(11):2114-2121. PubMed ID: 11053488
[TBL] [Abstract][Full Text] [Related]
14. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients.
van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
Nephrol Dial Transplant; 2013 Dec; 28(12):3062-71. PubMed ID: 23147161
[TBL] [Abstract][Full Text] [Related]
16. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
17. Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study.
Stepanova N; Driianska V; Korol L; Snisar L; Lebed L
Korean J Intern Med; 2022 Jan; 37(1):167-178. PubMed ID: 34167288
[TBL] [Abstract][Full Text] [Related]
18. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
[TBL] [Abstract][Full Text] [Related]
19. Association of gait speed and grip strength with risk of cardiovascular events in patients on haemodialysis: a prospective study.
Kuki A; Tanaka K; Kushiyama A; Tanaka Y; Motonishi S; Sugano Y; Furuya T; Ozawa T
BMC Nephrol; 2019 May; 20(1):196. PubMed ID: 31146702
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease--results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
Lepper PM; Kleber ME; Grammer TB; Hoffmann K; Dietz S; Winkelmann BR; Boehm BO; März W
Atherosclerosis; 2011 Nov; 219(1):291-7. PubMed ID: 21722903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
